Gene microarray analysis of experimental glaucomatous retina from cynomologous monkey

Investigative Ophthalmology and Visual Science

Volumn 44, Issue 10, 2003, Pages 4347-4356

  Miyahara, Teruyoshi ^a   Kikuchi, Takanobu ^a   Akimoto, Masayuki ^a   Kurokawa, Toru ^a   Shibuki, Hiroto ^a   Yoshimura, Nagahisa ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CERULOPLASMIN; GENE PRODUCT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARGON LASER; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION; GENETIC ANALYSIS; GLAUCOMA; IMMUNOHISTOCHEMISTRY; LASER COAGULATION; MONKEY; MUELLER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TRABECULAR MESHWORK; UNINDEXED SEQUENCE;

ANIMALS; CERULOPLASMIN; DISEASE MODELS, ANIMAL; EYE PROTEINS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION PROFILING; GLAUCOMA; GLIAL FIBRILLARY ACIDIC PROTEIN; INTRAOCULAR PRESSURE; LASER COAGULATION; MACACA FASCICULARIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RETINA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRABECULAR MESHWORK; UP-REGULATION;

EID: 0141764888     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.02-1032     Document Type: Article

References (51)

1. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol. 1996;80:389-393.
2. Garcia-Valenzuela E, Shareef S, Walsh J, Sharma SC. Programmed cell death of retinal ganglion cells during experimental glaucoma. Exp Eye Res. 1995;61:33-44.
3. Quigley HA, Nickelis RW, Kerrigan LA, Pease ME, Thibault DJ, Zack, DJ. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci. 1995;36:774-786.
4. Anderson DR, Hendrickson A. Effect of intraocular pressure on rapid axoplasmic transport in monkey optic nerve. Invest Ophthalmol Vis Sci. 1974;13:771-783.
5. Quigley HA, Addicks EM, Green WR, Maumenee AE. Optic nerve damage in human glaucoma. II. The site of injury and susceptibility to damage. Arch Ophthalmol. 1981;99:635-649.
6. Quigley HA, Anderson DR. The dynamics and location of axonal transport blockade by acute intraocular pressure elevation in primate optic nerve. Invest Ophthalmol Vis Sci. 1976;15:606-616.
7. Dreyer EB, Zurakowski D, Schumer RA, Podos SM, Lipton SA. Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch Ophthalmol. 1996;114:299-305.
8. Neufeld AH, Hernandez MR, Gonzalez M. Nitric oxide synthase in the human glaucomatous optic nerve head. Arch Ophthalmol. 1997;115:497-503.
9. Liu B, Neufeld AH. Expression of nitric oxide synthase-2 (NOS-2) in reactive astrocytes of the human glaucomatous optic nerve head. Glia. 2000;30:178-186.
10. Williams GT, Smith CA. Molecular regulation of apoptosis: genetic controls on cell death. Cell. 1993;74:777-779.
11. Johnson EC, Morrison JC, Farrell S, et al. The effect of chronically elevated intraocular pressure on the rat optic nerve head extracellular matrix. Exp Eye Res. 1996;62:663-674.
12. Morrison JC, Moore CG, Deppmeier LM, et al. A rat model of chronic pressure induced optic nerve damage. Exp Eye Res. 1997;64:85-96.
13. Shareef SR, Garcia-Valenzuela E, Saliemo A, Walsh J, Sharma SC. Chronic ocular hypertension following episcleral venous occlusion in rats. Exp Eye Res. 1995;61:379-382.
14. Ueda J, Sawaguchi S, Hanyu T, et al. Experimental glaucoma model in the rat induced by laser trabecular photocoagulation after an intracameral injection of Indian ink. Jpn J Ophthalmol. 1998;42:337-344.
15. Gaasterland D, Kupfer C. Experimental glaucoma in the rhesus monkey. Invest Ophthalmol Vis Sci. 1974;13:455-457.
16. Pederson JE, Gaasterland DE. Laser-induced primate glaucoma. I. Progression of cupping. Arch Ophthalmol. 1984;102:1689-1692.
17. Iyer VR, Eisen MB, Ross DT, et al. The transcriptional program in the response of human fibroblasts to serum. Science. 1999;283:83-87.
18. Duggan DJ, Bittner M, Chen Y, Meltzer P, Trent JM. Expression profiling using cDNA microarrays. Nat Genet. 1999;21:10-14.
19. Brown PO, Botstein D. Exploring the new world of the genome with DNA microarrays. Nat Genet. 1999;21:33-37.
20. Southern E, Mir K, Shchepinov M. Molecular interactions on microarrays. Nat Genet. 1999;21:5-9.
21. Sawaguchi S, Yue BY, Fukuchi T, et al. Collagen fibrillar network in the optic nerve head of normal monkey eyes and monkey eyes with laser-induced glaucoma-a scanning electron microscopic study. Curr Eye Res. 1999;18:143-149.
22. Fukuchi T, Sawaguchi S, Yue BY, Iwata K, Hara H, Kaiya T. Sulfated proteoglycans in the lamina cribrosa of normal monkey eyes and monkey eyes with laser-induced glaucoma. Exp Eye Res. 1994;58:231-243.
23. Perkin-Elmer Applied Biosystems: User Bulletin No. 2 (II December, 1997)
24. Shibuki H, Katai N, Yodoi J, Uchida K, Yoshimura N. Lipid peroxidation and peroxynitrite in retinal ischemia-reperfusion injury. Invest Ophthalmol Vis Sci. 2000;41:3607-3614.
25. INK4 in neuronal cell death after retinal ischemia-reperfusion injury. Invest Ophthalmol Vis Sci. 1999;40:528-533.
26. Tanihara H, Hangai M, Sawaguchi S, et al. Up-regulation of glial fibrillary acidic protein in the retina of primate eyes with experimental glaucoma. Arch Ophthalmol. 1997;115:752-756.
27. Levin LA, Geszvain KM. Expression of ceruloplasmin in the retina: induction after optic nerve crush. Invest Ophthalmol Vis Sci. 1998;39:157-163.
28. Zou J, Young S, Zhu F, et al. Microarray profile of differentially expressed genes in a monkey model of allergic asthma. Genome Biol. 2002;3:research0020.
29. Osada N, Hida M, Kusuda J, Tanuma R, Iseki K. Assignment of 118 novel cDNAs of cynomolgus monkey brain to human chromosomes. Gene. 2001;275:31-37.
30. Bigger CB, Brasky KM, Lanford RE. DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection. J Virol. 2001;75:7059-7066.
31. Kane MD, Jatkoe TA, Stumpf CR, et al. Assessment of the sensitivity and specificity of oligonucleotide (50mer) microarrays. Nucleic Acids Res. 2000;28:4552-4557.
32. Kelly K, Manos E, Jensen G, Nadauld L, Jones DA. APRIL/TRDL-1, a tumor necrosis factor-like ligand, stimulates cell death. Cancer Res. 2000;60:1021-1027.
33. Tezel G, Li LY, Patil RV, Wax MB. TNF-alpha and TNF-alpha receptor-1 in the retina of normal and glaucomatous eyes. Invest Ophthalmol Vis Sci. 2001;42:1787-1794.
34. Yuan L, Neufeld AH. Tumor necrosis factor-alpha: a potentially neurodestructive cytokine produced by glia in the human glaucomatous optic nerve head. Glia. 2000;32:42-50.
35. 39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways. Biochem J. 2002;365:119-126.
36. Tsuji T, Matsuyama Y, Natsume N, et el. Analysis of chondrex (YKL-40, HC gp-39) in the cerebrospinal fluid of patients with spine disease. Spine. 2002;27:732-735.
37. Yang J, Yang P, Tezel G, et al. Induction of HLA-DR expression in human lamina cribrosa astrocytes by cytokines and simulated ischemia. Invest Ophthalmol Vis Sci. 2001;42:365-371.
38. Vickers JC, Schumer RA, Podos SM, Wang RF, Riederer BM, Morrison JH. Differential vulnerability of neurochemically identified subpopulations of retinal neurons in a monkey model of glaucoma. Brain Res. 1995;680:23-35.
39. Grosche J, Hartig W, Reichenbach A. Expression of glial fibrillary acidic protein (GFAP), glutamine synthetase (GS), and Bcl-2 protooncogene protein by Müller (glial) cells in retinal light damage of rats. Neurosci Lett. 1995;185:119-122.
40. Osborne NN, Block F, Sontag KH. Reduction of ocular blood flow results in glial fibrillary acidic protein (GFAP) expression in rat retinal Müller cells. Vis Neurosci. 1991;7:637-639.
41. Newman E, Reichenbach A. The Müller cell: a functional element of the retina. Trends Neurosci. 1996;19:307-312.
42. Bringmann A, Reichenbach A. Role of Müller cells in retinal degenerations. Front Biosci. 2001;6:E72-E92.
43. McGahan MC, Fleisher LN. Antioxidant activity of aqueous and vitreous humor from the inflamed rabbit eye. Curr Eye Res. 1986;5:641-645.
44. Klomp LW, Gitlin JD., Expression of the ceruloplasmin gene in the human retina and brain: implications for a pathogenic model in aceruloplasminemia. Hum Mol Genet. 1996;5:1989-1996.
45. Loeffler DA, LeWitt PA, Juneau PL, et al. Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders. Brain Res. 1996;738:265-274.
46. Loeffler DA, DeMaggio AJ, Juneau PL, et al. Ceruloplasmin is increased in cerebrospinal fluid in Alzheimer's disease but not Parkinson's disease. Alzheimer Dis Assoc Disord. 1994;8:190-197.
47. Gutteridge JM. Antioxidant properties of caeruloplasmin towards iron- and copper dependent oxygen radical formation. FEBS Lett. 1983;157:37-40.
48. Chen L, Dentchev T, Wong R, et al. Increased expression of ceruloplasmin in the retina following photic injury. Mol Vis. 2003;30:151-158.
49. Yoshida K, Furihata K, Takeda S, et al. A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nat Genet. 1995;9:267-272.
50. Morita H, Ikeda S, Yamamoto K, et al. Hereditary ceruloplasmin deficiency with hemosiderosis: a clinicopathological study of a Japanese family. Ann Neurol. 1995;37:646-656.
51. Miyajima H, Nishimura Y, Mizoguchi K, et al. Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration. Neurology. 1987;37:761-767.